Assay News and Research

RSS

Novel amplification-free rapid SARS-CoV-2 nucleic acid detection platform based on HC-FIA

The COVID-19 pandemic has highlighted the need for rapid and accurate nucleic acid detection at the point of care.

11 Dec 2020

CRISPR-based test for COVID-19 provides quick, accurate results

Imagine swabbing your nostrils, putting the swab in a device, and getting a read-out on your phone in 15 to 30 minutes that tells you if you are infected with the COVID-19 virus.

7 Dec 2020

Chemical compounds in foods can inhibit a key SARS-Cov-2 enzyme

Chemical compounds in foods or beverages like green tea and dark chocolate can bind to and block the function of an enzyme in SARS-CoV-2.

3 Dec 2020

New method could more sensitively detect circulating tumor cells

Breast cancer is the most frequently diagnosed cancer in women, and metastasis from the breast to other areas of the body is the leading cause of death in these patients.

19 Nov 2020

Highly automated device rapidly detects the presence of COVID-19

Throughout the pandemic, infectious disease experts and frontline medical workers have asked for a faster, cheaper and more reliable COVID-19 test.

6 Nov 2020

Developing a new method to reduce antibiotic resistance in waterways

Dr. Aimee Murray speaks to AZoLifeSciences about her latest research that looks at a way of reducing antibiotic resistance build-up in waterways.

From University of Exeter 4 Nov 2020

Individuals infected with mild-to-moderate COVID 19 mount a robust antibody response

The vast majority of individuals infected with mild-to-moderate COVID 19 mount a robust antibody response that is relatively stable for at least five months, according to research conducted at the Icahn School of Medicine at Mount Sinai and published October 28, in the journal Science.

29 Oct 2020

Serologic testing of COVID-19 patients as an adjunct diagnostic method

A recent paper explored the possibility of using serologic testing as an adjunct diagnostic method in the diagnosis of SARS-CoV-2 infection.

28 Oct 2020

Exploiting CRISPR systems for the fast detection of SARS-CoV-2

A paper published on medRxiv describes a repurposed type III CRISPR-Cas system that can detect the virus from nasopharyngeal swabs in less than an hour.

26 Oct 2020

Study: Early travel restrictions have significantly limited the spread of COVID-19 virus

The coronavirus, responsible for the COVID-19 pandemic, has one official name--SARS-CoV-2. But according to virologists, mutations lead to hundreds of genetically-distinct versions of the virus.

23 Oct 2020

Simple skin test can accurately identify Parkinson's disease

New research shows a simple skin test can accurately identify Parkinson's disease, demonstrating for the first time the feasibility of the method. Currently diagnosed by clinical signs and symptoms but only definitively diagnosed at autopsy, Parkinson's disease is commonly misdiagnosed early in the disease course, complicating clinical trials of potential treatments.

22 Oct 2020

Scientists develop novel lab testing procedure for detection of SARS-CoV-2 antibodies

Knowing you have developed antibodies against the SARS-CoV-2 virus after recovering from COVID-19 doesn't tell you everything about your immunity.

20 Oct 2020

SARS-CoV-2 may induce long-term autoimmune disorder due to self-glycan antibody production

A new study indicated that many of the unusual symptoms of SARS-CoV-2 infections may be due to induced autoimmune responses.

20 Oct 2020

New laboratory test can capture and analyze the deadliest cells in brain cancer

Researchers have designed a laboratory test that can precisely examine the deadliest cells found in the most common and aggressive type of brain cancer.

19 Oct 2020

New technology rapidly diagnoses sickle cell disease

Researchers at the University of Colorado Boulder and the University of Colorado Anschutz Medical Campus have developed a new way to diagnose diseases of the blood like sickle cell disease with sensitivity and precision and in only one minute.

16 Oct 2020

Krystal binding microplates set a new standard for uniform, reproducible capture of biomolecules

Porvair Sciences new medium and high bind Krystal microplates set a new standard for uniform and reproducible capture of a wide range of biomolecules ready for affinity binding assays such as ELISA's.

From Porvair Sciences Limited 16 Oct 2020

Army researchers test alternative ways to measure COVID-19 antibody levels

Researchers with the U.S. Army Futures Command are part of a team that tested alternative ways to measure COVID-19 antibody levels, resulting in a process that is faster, easier and less expensive to use on a large scale. Their method holds promise for accurately identifying potential donors who have the best chance of helping infected patients through convalescent plasma therapy.

15 Oct 2020